As noninvasive prenatal aneuploidy testing gains popularity among doctors and patients, the field of providers keeps growing. One of the latest entrants is NIPD Genetics of Cyprus, which launched its Veracity test in June.
Veracity, which is based on a proprietary targeted sequencing and analysis approach and is currently performed in NIPD Genetics’ laboratory in Nicosia, screens for trisomies 21, 18, and 13 and determines fetal sex. The test can be administered from week 10 of gestation, has an average turnaround time of seven business days, and is competitively priced, with cost varying between countries, according to CEO Philippos Patsalis.
Hey, check out all the engineering jobs. Post your resume today!
